United States In Vitro Diagnostics Market, Impact of COVID-19, Industry Trends, Growth, Opportunity Company Overview, Sales Analysis, Forecast
In-vitro diagnostic is an advanced method that provides new tools to find disease diagnosis and treatment. In the United States, the growing prevalence of chronic and infectious diseases has spurred the development of the in-vitro diagnostics (IVD) market. In-vitro diagnostics (IVDs) in the US is considerably more than simple assays conducted in test tubes and examining glass dishes under microscopes. These instruments used to analyze body fluids and tissue samples collected from a patient. The United States In-vitro Diagnostics Market Size was worth US$ 26.9 Billion in 2020.
Besides, the United States In-Vitro Diagnostic market is broad and has various types of diagnostics instruments to perform different techniques. Clinical Chemistry, Microbiology–Molecular, POC–Professional, OTC Diabetes, Immunoassay–Infectious, Histology, Hematology, and Blood Testing are popular IVD techniques in the U.S.A. The growth of POC diagnostic market in the States is phenomenal. These POC diagnostics products have been developed to use at a patient’s bedside in hospitals to get instant results without sending the samples to the lab. Innovations in Microbiology and Immunochemistry diagnostic fields have made these tests economically viable and provide quicker and more precise results.
Further In-Vitro diagnostics are used in large-scale population screenings such as for cervical cancer. As well as predicting, whether a particular medicine or therapy would work on a patient. Patients with diabetes use IVDs to test their blood glucose levels regularly. At the same time it is also used to make or confirm a medical diagnosis, such as confirming a pregnancy or testing infectious diseases like HIV or hepatitis. According to Renub Research, United States In Vitro Diagnostics Market will be US$ 35.3 Billion opportunities by 2026.
The United States In-Vitro Diagnostics have vast product ranges. The reagents segment fastest-growing product in the In-Vitro Diagnostics market as the increasing volume of tests and the rise in R&D initiatives pertaining to reagents. Instrument product is also seen to dominate the market in the forecast period because of rising approval of COVID-19 tests for emergency use by the regulatory authorities. In the United States, the In-vitro diagnostics market is currently in the South of the country, followed by the West being second. As per our research findings, United States IVD Industry will further grow with a CAGR of 4.63% during 2020-2026.
Factors Driving the United States IVD Market
The growth factors like the increasing prevalence of chronic diseases such as heart disease, cancer, asthma, and diabetes are driving the In Vitro Diagnostics market in the United States. Thereon diseases, as mentioned earlier, were responsible for the majority of deaths in the United States, killing over 1.7 million people each year. IVD products used to diagnose and monitor these disorders. As a result, IVDs have proven to be effective in treating and diagnosing several chronic illnesses. However, a lack of effective reimbursement regulations and a shortage of experienced lab technicians are the challenges that are hindering the market's growth.
Coronavirus Impact on IVD Industry of United States
The in-vitro diagnostics industry has seen a huge spurt in demand due to the Covid-19 Pandemic. Primary assays used for COVID-19 detection employ the RT-PCR technique. Although the traditional test takes 5 to 6 hours to produce a result, POC assays (Rapid Antigen Test) have drastically decreased the time. Thus, COVID-19 presents a significant opportunity for the IVD industry's leading stakeholders. As a result, the overall impact of the COVID-19 pandemic on substantial companies in the in vitro diagnostics sector remained positive. Few organizations experiencing a setback due to the lockdown have decreased the amount of regular IVD tests completed across the United States. However, the rapid demand for newly available emergency use permitted IVD tests for COVID-19 detection offsets this negative impact.
Renub Research report titled “United States In Vitro Diagnostics Market, IVD Segments (Clinical Chemistry, Microbiology – Molecular, Microbiology -ID/AST, POC - OTC Diabetes, POC – Professional, POC – Others, Immunoassay – Infectious, Immunoassay – Others, Urinalysis, Histology, Hematology, Molecular - Non Infectious, Coagulation, Blood Testing and Typing, Flow Cytometry), Products (Services, Reagents, Software, Instruments) Regions (Midwest, South, North East West), Companies (Roche Diagnostics, Thermo Fisher Scientific, Siemens Healthineers, Danaher Corporation, Abbott Diagnostics, Sysmex Corporation)” provides a complete analysis of United States In Vitro Diagnostics (IVD) Market.
Segments - United States In-Vitro Diagnostics (IVD) Market
1. Clinical chemistry
2. Microbiology -ID/AST
3. Microbiology – Molecular
4. POC – Professional
5. POC - OTC Diabetes
6. POC – Others
7. Immunoassay – Infectious
8. Immunoassay – Others
9. Urinalysis
10. Molecular - Non Infectious
11. Coagulation
12. Histology
13. Hematology
14. Blood Testing and Typing
15. Flow Cytometry
Products - United States In-Vitro Diagnostics (IVD) Market
1. Services
2. Software
3. Reagents
4. Instruments
Regions - United States In-Vitro Diagnostics (IVD) Market
1. South
2. West
3. Midwest
4. North East
All the companies have been studied from three points
1. Roche Diagnostics
2. Abbott Diagnostics
3. Siemens Healthineers
4. Danaher Corporation
5. Thermo Fisher Scientific
6. Sysmex Corporation
Besides, the United States In-Vitro Diagnostic market is broad and has various types of diagnostics instruments to perform different techniques. Clinical Chemistry, Microbiology–Molecular, POC–Professional, OTC Diabetes, Immunoassay–Infectious, Histology, Hematology, and Blood Testing are popular IVD techniques in the U.S.A. The growth of POC diagnostic market in the States is phenomenal. These POC diagnostics products have been developed to use at a patient’s bedside in hospitals to get instant results without sending the samples to the lab. Innovations in Microbiology and Immunochemistry diagnostic fields have made these tests economically viable and provide quicker and more precise results.
Further In-Vitro diagnostics are used in large-scale population screenings such as for cervical cancer. As well as predicting, whether a particular medicine or therapy would work on a patient. Patients with diabetes use IVDs to test their blood glucose levels regularly. At the same time it is also used to make or confirm a medical diagnosis, such as confirming a pregnancy or testing infectious diseases like HIV or hepatitis. According to Renub Research, United States In Vitro Diagnostics Market will be US$ 35.3 Billion opportunities by 2026.
The United States In-Vitro Diagnostics have vast product ranges. The reagents segment fastest-growing product in the In-Vitro Diagnostics market as the increasing volume of tests and the rise in R&D initiatives pertaining to reagents. Instrument product is also seen to dominate the market in the forecast period because of rising approval of COVID-19 tests for emergency use by the regulatory authorities. In the United States, the In-vitro diagnostics market is currently in the South of the country, followed by the West being second. As per our research findings, United States IVD Industry will further grow with a CAGR of 4.63% during 2020-2026.
Factors Driving the United States IVD Market
The growth factors like the increasing prevalence of chronic diseases such as heart disease, cancer, asthma, and diabetes are driving the In Vitro Diagnostics market in the United States. Thereon diseases, as mentioned earlier, were responsible for the majority of deaths in the United States, killing over 1.7 million people each year. IVD products used to diagnose and monitor these disorders. As a result, IVDs have proven to be effective in treating and diagnosing several chronic illnesses. However, a lack of effective reimbursement regulations and a shortage of experienced lab technicians are the challenges that are hindering the market's growth.
Coronavirus Impact on IVD Industry of United States
The in-vitro diagnostics industry has seen a huge spurt in demand due to the Covid-19 Pandemic. Primary assays used for COVID-19 detection employ the RT-PCR technique. Although the traditional test takes 5 to 6 hours to produce a result, POC assays (Rapid Antigen Test) have drastically decreased the time. Thus, COVID-19 presents a significant opportunity for the IVD industry's leading stakeholders. As a result, the overall impact of the COVID-19 pandemic on substantial companies in the in vitro diagnostics sector remained positive. Few organizations experiencing a setback due to the lockdown have decreased the amount of regular IVD tests completed across the United States. However, the rapid demand for newly available emergency use permitted IVD tests for COVID-19 detection offsets this negative impact.
Renub Research report titled “United States In Vitro Diagnostics Market, IVD Segments (Clinical Chemistry, Microbiology – Molecular, Microbiology -ID/AST, POC - OTC Diabetes, POC – Professional, POC – Others, Immunoassay – Infectious, Immunoassay – Others, Urinalysis, Histology, Hematology, Molecular - Non Infectious, Coagulation, Blood Testing and Typing, Flow Cytometry), Products (Services, Reagents, Software, Instruments) Regions (Midwest, South, North East West), Companies (Roche Diagnostics, Thermo Fisher Scientific, Siemens Healthineers, Danaher Corporation, Abbott Diagnostics, Sysmex Corporation)” provides a complete analysis of United States In Vitro Diagnostics (IVD) Market.
Segments - United States In-Vitro Diagnostics (IVD) Market
1. Clinical chemistry
2. Microbiology -ID/AST
3. Microbiology – Molecular
4. POC – Professional
5. POC - OTC Diabetes
6. POC – Others
7. Immunoassay – Infectious
8. Immunoassay – Others
9. Urinalysis
10. Molecular - Non Infectious
11. Coagulation
12. Histology
13. Hematology
14. Blood Testing and Typing
15. Flow Cytometry
Products - United States In-Vitro Diagnostics (IVD) Market
1. Services
2. Software
3. Reagents
4. Instruments
Regions - United States In-Vitro Diagnostics (IVD) Market
1. South
2. West
3. Midwest
4. North East
All the companies have been studied from three points
- Overview
- Recent Developments
- Sales Analysis
1. Roche Diagnostics
2. Abbott Diagnostics
3. Siemens Healthineers
4. Danaher Corporation
5. Thermo Fisher Scientific
6. Sysmex Corporation
1. INTRODUCTION
2. RESEARCH & METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Growth Drivers
4.2 Challenges
5. UNITED STATES IN-VITRO DIAGNOSTICS (IVD) MARKET
6. MARKET SHARE – UNITED STATES IN-VITRO DIAGNOSTICS (IVD) ANALYSIS
6.1 By Segments
6.2 By Products
6.3 By Regions
7. SEGMENTS – UNITED STATES IN-VITRO DIAGNOSTICS (IVD) MARKET
7.1 Clinical Chemistry
7.2 Microbiology -ID/AST
7.3 Microbiology – Molecular
7.4 POC – Professional
7.5 POC - OTC Diabetes
7.6 POC – Others
7.7 Immunoassay – Infectious
7.8 Immunoassay – Others
7.9 Urinalysis
7.10 Molecular - Non Infectious
7.11 Coagulation
7.12 Histology
7.13 Hematology
7.14 Blood Testing and Typing
7.15 Flow Cytometry
8. PRODUCTS – UNITED STATES IN-VITRO DIAGNOSTICS (IVD) MARKET
8.1 Services
8.2 Software
8.3 Reagents
8.4 Instruments
9. REGIONS – UNITED STATES IN-VITRO DIAGNOSTICS (IVD) MARKET
9.1 South
9.2 West
9.3 Midwest
9.4 North East
10. COMPANY ANALYSIS
10.1 Roche Diagnostics
10.1.1 Overview
10.1.2 Recent Developments
10.1.3 Sales
10.2 Abbott Diagnostics
10.2.1 Overview
10.2.2 Recent Developments
10.2.3 Sales
10.3 Siemens Healthineers
10.3.1 Overview
10.3.2 Recent Developments
10.3.3 Sales
10.4 Danaher Corporation
10.4.1 Overview
10.4.2 Recent Developments
10.4.3 Sales
10.5 Thermo Fisher Scientific
10.5.1 Overview
10.5.2 Recent Developments
10.5.3 Sales
10.6 Sysmex Corporation
10.6.1 Overview
10.6.2 Recent Developments
10.6.3 Sales
List Of Figures:
Figure-01: United States IVD Market (Million US$), 2016 – 2020
Figure-02: Forecast for – United States IVD Market (Million US$), 2021 – 2026
Figure-03: Segment – Clinical Chemistry Market (Million US$), 2016 – 2020
Figure-04: Segment – Forecast for Clinical Chemistry Market (Million US$), 2021 – 2026
Figure-05: Segment – Microbiology - ID/AST Market (Million US$), 2016 – 2020
Figure-06: Segment – Forecast for Microbiology - ID/AST Market (Million US$), 2021 – 2026
Figure-07: Segment – Microbiology – Molecular Market (Million US$), 2016 – 2020
Figure-08: Segment – Forecast for Microbiology – Molecular Market (Million US$), 2021 – 2026
Figure-09: Segment – POC – Professional Market (Million US$), 2016 – 2020
Figure-10: Segment – Forecast for POC – Professional Market (Million US$), 2021 – 2026
Figure-11: Segment – POC – OTC Diabetes Market (Million US$), 2016 – 2020
Figure-12: Segment – Forecast for POC – OTC Diabetes Market (Million US$), 2021 – 2026
Figure-13: Segment – POC – Others Market (Million US$), 2016 – 2020
Figure-14: Segment – Forecast for POC – Others Market (Million US$), 2021 – 2026
Figure-15: Segment – Immunoassay – Infectious Market (Million US$), 2016 – 2020
Figure-16: Segment – Forecast for Immunoassay – Infectious Market (Million US$), 2021 – 2026
Figure-17: Segment – Immunoassay – Others Market (Million US$), 2016 – 2020
Figure-18: Segment – Forecast for Immunoassay – Others Market (Million US$), 2021 – 2026
Figure-19: Segment – Urinalysis Market (Million US$), 2016 – 2020
Figure-20: Segment – Forecast for Urinalysis Market (Million US$), 2021 – 2026
Figure-21: Segment – Molecular - Non Infectious Market (Million US$), 2016 – 2020
Figure-22: Segment – Forecast for Molecular - Non Infectious Market (Million US$), 2021 – 2026
Figure-23: Segment – Coagulation Market (Million US$), 2016 – 2020
Figure-24: Segment – Forecast for Coagulation Market (Million US$), 2021 – 2026
Figure-25: Segment – Histology Market (Million US$), 2016 – 2020
Figure-26: Segment – Forecast for Histology Market (Million US$), 2021 – 2026
Figure-27: Segment – Hematology Market (Million US$), 2016 – 2020
Figure-28: Segment – Forecast for Hematology Market (Million US$), 2021 – 2026
Figure-29: Segment – Blood Testing and Typing Market (Million US$), 2016 – 2020
Figure-30: Segment – Forecast for Blood Testing and Typing Market (Million US$), 2021 – 2026
Figure-31: Segment – Flow Cytometrys Market (Million US$), 2016 – 2020
Figure-32: Segment – Forecast for Flow Cytometrys Market (Million US$), 2021 – 2026
Figure-33: Products – Services Market (Million US$), 2016 – 2020
Figure-34: Products – Forecast for Services Market (Million US$), 2021 – 2026
Figure-35: Products – Software Market (Million US$), 2016 – 2020
Figure-36: Products – Forecast for Software Market (Million US$), 2021 – 2026
Figure-37: Products – Reagents Market (Million US$), 2016 – 2020
Figure-38: Products – Forecast for Reagents Market (Million US$), 2021 – 2026
Figure-39: Products – Instruments Market (Million US$), 2016 – 2020
Figure-40: Products – Forecast for Instruments Market (Million US$), 2021 – 2026
Figure-41: South – In-Vitro Diagnostics (IVD) Market (Million US$), 2016 – 2020
Figure-42: South – Forecast for In-Vitro Diagnostics (IVD) Market (Million US$), 2021 – 2026
Figure-43: West – In-Vitro Diagnostics (IVD) Market (Million US$), 2016 – 2020
Figure-44: West – Forecast for In-Vitro Diagnostics (IVD) Market (Million US$), 2021 – 2026
Figure-45: Midwest – In-Vitro Diagnostics (IVD) Market (Million US$), 2016 – 2020
Figure-46: Midwest – Forecast for In-Vitro Diagnostics (IVD) Market (Million US$), 2021 – 2026
Figure-47: North East – In-Vitro Diagnostics (IVD) Market (Million US$), 2016 – 2020
Figure-48: North East – Forecast for In-Vitro Diagnostics (IVD) Market (Million US$), 2021 – 2026
Figure-49: Roche Diagnostics – Global Revenue (Million US$), 2016 – 2020
Figure-50: Roche Diagnostics – Forecast for Global Revenue (Million US$), 2021 – 2026
Figure-51: Abbott Diagnostics – Global Revenue (Million US$), 2016 – 2020
Figure-52: Abbott Diagnostics – Forecast for Global Revenue (Million US$), 2021 – 2026
Figure-53: Siemens Healthineers – Global Revenue (Million US$), 2016 – 2020
Figure-54: Siemens Healthineers – Forecast for Global Revenue (Million US$), 2021 – 2026
Figure-55: Danaher Corporation – Global Revenue (Million US$), 2016 – 2020
Figure-56: Danaher Corporation – Forecast for Global Revenue (Million US$), 2021 – 2026
Figure-57: Thermo Fisher Scientific. – Global Revenue (Million US$), 2016 – 2020
Figure-58: Thermo Fisher Scientific. – Forecast for Global Revenue (Million US$), 2021 – 2026
Figure-59: Sysmex Corporation – Global Revenue (Million US$), 2016 – 2020
Figure-60: Sysmex Corporation – Forecast for Global Revenue (Million US$), 2021 – 2026
List Of Tables:
Table-01: United States – IVD Market Share by Segment (Percent), 2016 – 2020
Table-02: United States – Forecast for IVD Market Share by Segment (Percent), 2021 – 2026
Table-03: United States – IVD Market Share by Product (Percent), 2016 – 2020
Table-04: United States – Forecast for IVD Market Share by Product (Percent), 2021 – 2026
Table-05: United States – IVD Market Share by Region (Percent), 2016 – 2020
Table-06: United States – Forecast for IVD Market Share by Region (Percent), 2021 – 2026
2. RESEARCH & METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Growth Drivers
4.2 Challenges
5. UNITED STATES IN-VITRO DIAGNOSTICS (IVD) MARKET
6. MARKET SHARE – UNITED STATES IN-VITRO DIAGNOSTICS (IVD) ANALYSIS
6.1 By Segments
6.2 By Products
6.3 By Regions
7. SEGMENTS – UNITED STATES IN-VITRO DIAGNOSTICS (IVD) MARKET
7.1 Clinical Chemistry
7.2 Microbiology -ID/AST
7.3 Microbiology – Molecular
7.4 POC – Professional
7.5 POC - OTC Diabetes
7.6 POC – Others
7.7 Immunoassay – Infectious
7.8 Immunoassay – Others
7.9 Urinalysis
7.10 Molecular - Non Infectious
7.11 Coagulation
7.12 Histology
7.13 Hematology
7.14 Blood Testing and Typing
7.15 Flow Cytometry
8. PRODUCTS – UNITED STATES IN-VITRO DIAGNOSTICS (IVD) MARKET
8.1 Services
8.2 Software
8.3 Reagents
8.4 Instruments
9. REGIONS – UNITED STATES IN-VITRO DIAGNOSTICS (IVD) MARKET
9.1 South
9.2 West
9.3 Midwest
9.4 North East
10. COMPANY ANALYSIS
10.1 Roche Diagnostics
10.1.1 Overview
10.1.2 Recent Developments
10.1.3 Sales
10.2 Abbott Diagnostics
10.2.1 Overview
10.2.2 Recent Developments
10.2.3 Sales
10.3 Siemens Healthineers
10.3.1 Overview
10.3.2 Recent Developments
10.3.3 Sales
10.4 Danaher Corporation
10.4.1 Overview
10.4.2 Recent Developments
10.4.3 Sales
10.5 Thermo Fisher Scientific
10.5.1 Overview
10.5.2 Recent Developments
10.5.3 Sales
10.6 Sysmex Corporation
10.6.1 Overview
10.6.2 Recent Developments
10.6.3 Sales
List Of Figures:
Figure-01: United States IVD Market (Million US$), 2016 – 2020
Figure-02: Forecast for – United States IVD Market (Million US$), 2021 – 2026
Figure-03: Segment – Clinical Chemistry Market (Million US$), 2016 – 2020
Figure-04: Segment – Forecast for Clinical Chemistry Market (Million US$), 2021 – 2026
Figure-05: Segment – Microbiology - ID/AST Market (Million US$), 2016 – 2020
Figure-06: Segment – Forecast for Microbiology - ID/AST Market (Million US$), 2021 – 2026
Figure-07: Segment – Microbiology – Molecular Market (Million US$), 2016 – 2020
Figure-08: Segment – Forecast for Microbiology – Molecular Market (Million US$), 2021 – 2026
Figure-09: Segment – POC – Professional Market (Million US$), 2016 – 2020
Figure-10: Segment – Forecast for POC – Professional Market (Million US$), 2021 – 2026
Figure-11: Segment – POC – OTC Diabetes Market (Million US$), 2016 – 2020
Figure-12: Segment – Forecast for POC – OTC Diabetes Market (Million US$), 2021 – 2026
Figure-13: Segment – POC – Others Market (Million US$), 2016 – 2020
Figure-14: Segment – Forecast for POC – Others Market (Million US$), 2021 – 2026
Figure-15: Segment – Immunoassay – Infectious Market (Million US$), 2016 – 2020
Figure-16: Segment – Forecast for Immunoassay – Infectious Market (Million US$), 2021 – 2026
Figure-17: Segment – Immunoassay – Others Market (Million US$), 2016 – 2020
Figure-18: Segment – Forecast for Immunoassay – Others Market (Million US$), 2021 – 2026
Figure-19: Segment – Urinalysis Market (Million US$), 2016 – 2020
Figure-20: Segment – Forecast for Urinalysis Market (Million US$), 2021 – 2026
Figure-21: Segment – Molecular - Non Infectious Market (Million US$), 2016 – 2020
Figure-22: Segment – Forecast for Molecular - Non Infectious Market (Million US$), 2021 – 2026
Figure-23: Segment – Coagulation Market (Million US$), 2016 – 2020
Figure-24: Segment – Forecast for Coagulation Market (Million US$), 2021 – 2026
Figure-25: Segment – Histology Market (Million US$), 2016 – 2020
Figure-26: Segment – Forecast for Histology Market (Million US$), 2021 – 2026
Figure-27: Segment – Hematology Market (Million US$), 2016 – 2020
Figure-28: Segment – Forecast for Hematology Market (Million US$), 2021 – 2026
Figure-29: Segment – Blood Testing and Typing Market (Million US$), 2016 – 2020
Figure-30: Segment – Forecast for Blood Testing and Typing Market (Million US$), 2021 – 2026
Figure-31: Segment – Flow Cytometrys Market (Million US$), 2016 – 2020
Figure-32: Segment – Forecast for Flow Cytometrys Market (Million US$), 2021 – 2026
Figure-33: Products – Services Market (Million US$), 2016 – 2020
Figure-34: Products – Forecast for Services Market (Million US$), 2021 – 2026
Figure-35: Products – Software Market (Million US$), 2016 – 2020
Figure-36: Products – Forecast for Software Market (Million US$), 2021 – 2026
Figure-37: Products – Reagents Market (Million US$), 2016 – 2020
Figure-38: Products – Forecast for Reagents Market (Million US$), 2021 – 2026
Figure-39: Products – Instruments Market (Million US$), 2016 – 2020
Figure-40: Products – Forecast for Instruments Market (Million US$), 2021 – 2026
Figure-41: South – In-Vitro Diagnostics (IVD) Market (Million US$), 2016 – 2020
Figure-42: South – Forecast for In-Vitro Diagnostics (IVD) Market (Million US$), 2021 – 2026
Figure-43: West – In-Vitro Diagnostics (IVD) Market (Million US$), 2016 – 2020
Figure-44: West – Forecast for In-Vitro Diagnostics (IVD) Market (Million US$), 2021 – 2026
Figure-45: Midwest – In-Vitro Diagnostics (IVD) Market (Million US$), 2016 – 2020
Figure-46: Midwest – Forecast for In-Vitro Diagnostics (IVD) Market (Million US$), 2021 – 2026
Figure-47: North East – In-Vitro Diagnostics (IVD) Market (Million US$), 2016 – 2020
Figure-48: North East – Forecast for In-Vitro Diagnostics (IVD) Market (Million US$), 2021 – 2026
Figure-49: Roche Diagnostics – Global Revenue (Million US$), 2016 – 2020
Figure-50: Roche Diagnostics – Forecast for Global Revenue (Million US$), 2021 – 2026
Figure-51: Abbott Diagnostics – Global Revenue (Million US$), 2016 – 2020
Figure-52: Abbott Diagnostics – Forecast for Global Revenue (Million US$), 2021 – 2026
Figure-53: Siemens Healthineers – Global Revenue (Million US$), 2016 – 2020
Figure-54: Siemens Healthineers – Forecast for Global Revenue (Million US$), 2021 – 2026
Figure-55: Danaher Corporation – Global Revenue (Million US$), 2016 – 2020
Figure-56: Danaher Corporation – Forecast for Global Revenue (Million US$), 2021 – 2026
Figure-57: Thermo Fisher Scientific. – Global Revenue (Million US$), 2016 – 2020
Figure-58: Thermo Fisher Scientific. – Forecast for Global Revenue (Million US$), 2021 – 2026
Figure-59: Sysmex Corporation – Global Revenue (Million US$), 2016 – 2020
Figure-60: Sysmex Corporation – Forecast for Global Revenue (Million US$), 2021 – 2026
List Of Tables:
Table-01: United States – IVD Market Share by Segment (Percent), 2016 – 2020
Table-02: United States – Forecast for IVD Market Share by Segment (Percent), 2021 – 2026
Table-03: United States – IVD Market Share by Product (Percent), 2016 – 2020
Table-04: United States – Forecast for IVD Market Share by Product (Percent), 2021 – 2026
Table-05: United States – IVD Market Share by Region (Percent), 2016 – 2020
Table-06: United States – Forecast for IVD Market Share by Region (Percent), 2021 – 2026
